Journal article icon

Journal article

Response of 1,5‐anhydroglucitol level to intensive glucose‐ and blood‐pressure lowering interventions, and its associations with clinical outcomes in the ADVANCE trial

Abstract:

Aims

To evaluate 1,5‐anhydroglucitol (1,5‐AG) according to clinical outcomes and assess the effects of glucose‐ and blood pressure‐lowering interventions on change in 1,5‐AG levels in people with type 2 diabetes.

Methods

We measured 1,5‐AG in 6826 stored samples at baseline and in a random subsample of 684 participants at the 1‐year follow‐up visit in the ADVANCE trial. We examined baseline 1,5‐AG [

Expand abstract
Publication status:
Published
Peer review status:
Peer reviewed

Actions


Access Document


Files:
Publisher copy:
10.1111/dom.13755

Authors


More by this author
Role:
Author
ORCID:
0000-0001-6923-7151
Publisher:
Wiley
Journal:
Diabetes, Obesity and Metabolism More from this journal
Volume:
21
Issue:
8
Pages:
2017-2023
Publication date:
2019-05-29
Acceptance date:
2019-04-30
DOI:
EISSN:
1463-1326
ISSN:
1462-8902
Pmid:
31050156
Language:
English
Keywords:
Pubs id:
pubs:995957
UUID:
uuid:aaaaf6c6-0a80-4072-ab21-5fa7ff7ceca2
Local pid:
pubs:995957
Source identifiers:
995957
Deposit date:
2019-05-15

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP